Oppfølging etter metastasektomi hos pasienter med nyrekreft

Inclusion Criteria:

• Patients with histologically or cytologically confirmed renal cell carcinoma (RCC)

• Patients have clinical reasons for undergoing a surgical resection of tumor; there are two main categories of patients:

  • Patients with fully resectable disease as defined by lesions accessible by a surgeon during no more than two separate surgical sessions, and are expected to be rendered surgically no evidence of disease (NED)
  • Patients undergoing a noncurative procedure for relief of symptoms or for management of threatening lesions

• Patients have been deemed resectable by the subspecialty surgeon involved in the patient's care

• Patients must give written informed consent prior to initiation of therapy, in keeping with the policies of the institution; patients with a history of major psychiatric illness must be judged able to fully understand the investigational nature of the study and the risks associated with the therapy; the only approved consent is attached to this protocol

• Patients must have ability to comply with study and/or follow-up procedures

• Members of all races and ethnic groups are eligible for this trial

Exclusion Criteria:

• Patients must not have active acute infections that could be worsened by surgery or interfere with this study
• Patients must not have clinically significant cardiovascular disease, or peripheral vascular disease that creates an unacceptably high operative risk
• Patients must not have history of other diseases, metabolic dysfunction, physical examination finding, or clinical laboratory finding giving reasonable suspicion of a disease or condition that contraindicates surgical resection, or render the subject at high risk from treatment complications
• Patients must not have a history of uncontrolled severe depression